KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Intangibles: 2009-2025

Historic Intangibles for Vertex Pharmaceuticals (VRTX) over the last 14 years, with Sep 2025 value amounting to $429.8 million.

  • Vertex Pharmaceuticals' Intangibles fell 48.32% to $429.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $429.8 million, marking a year-over-year decrease of 48.32%. This contributed to the annual value of $825.9 million for FY2024, which is 1.67% down from last year.
  • According to the latest figures from Q3 2025, Vertex Pharmaceuticals' Intangibles is $429.8 million, which was down 1.31% from $435.5 million recorded in Q2 2025.
  • Vertex Pharmaceuticals' 5-year Intangibles high stood at $839.9 million for Q4 2023, and its period low was $387.0 million during Q2 2022.
  • Moreover, its 3-year median value for Intangibles was $603.6 million (2023), whereas its average is $662.5 million.
  • As far as peak fluctuations go, Vertex Pharmaceuticals' Intangibles surged by 55.97% in 2023, and later tumbled by 48.32% in 2025.
  • Quarterly analysis of 5 years shows Vertex Pharmaceuticals' Intangibles stood at $400.0 million in 2021, then soared by 50.90% to $603.6 million in 2022, then soared by 39.15% to $839.9 million in 2023, then decreased by 1.67% to $825.9 million in 2024, then tumbled by 48.32% to $429.8 million in 2025.
  • Its Intangibles was $429.8 million in Q3 2025, compared to $435.5 million in Q2 2025 and $441.2 million in Q1 2025.